Moss Beach, CA, United States of America

Philip E Hass

This inventor holds 25 USPTO granted patents and 19 published patent applications and 4 EPO patents, primarily in Biopharmaceuticals. Top assignee: Genentech, Inc.. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip E Hass. Retrieved from https://idiyas.com/inventor/philip-e-hass

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 19)

% Patents Active = 64.0

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 6.7

ph-index = 6

Forward Citations = 84(Granted Patents)

Location History:

South San Francisco, CA (US) (2020 - 2021)
Moss Beach, CA (US) (2003 - 2024)

Company Filing History:

25 out of 3,300

Genentech, Inc.

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

IL-22 Fc Fusion Proteins

Anti-Interleukin-33 Antibodies

Cardiovascular Treatments

Metabolic Syndrome

Wound Healing

Complement-Associated Conditions

Anti-Factor D Antibodies

Inflammatory Bowel Disease

Nucleic Acids

Antibodies

Thrombotic Disorders

Crystal Structure

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11999787 - Tie2-binding agents and methods of use (2024-06-04),

2. 11725050 - Anti-interleukin-33 antibodies and uses thereof (2023-08-15),

3. 11332507 - IL-22 Fc fusion proteins (2022-05-17),

4. 11155591 - Methods of treating acute pancreatitis using IL-22 fc fusion proteins (2021-10-26),

5. 11136365 - Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins (2021-10-05),

6. 11130791 - Methods for treating metabolic syndrome using IL-22 Fc fusion proteins (2021-09-28),

7. 10961313 - Anti-factor D antibody variant conjugates and uses thereof (2021-03-30),

8. 10723795 - Anti-interleukin-33 antibodies and uses thereof (2020-07-28),

9. 10654932 - Anti-factor D antibody variant conjugates and uses thereof (2020-05-19),

10. 10584155 - Pharmaceutical compositions of IL-22 Fc fusion proteins (2020-03-10),

11. 10544198 - Methods of accelerating or improving wound healing using IL-22 FC fusion proteins (2020-01-28),

12. 10179821 - Anti-factor D antibodies (2019-01-15),

13. 10160793 - Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins (2018-12-25),

14. 10093730 - Anti-interleukin-33 antibodies and uses thereof (2018-10-09),

15. 10087227 - Nucleic acids encoding IL-22 Fc fusion proteins (2018-10-02),

Title: The Innovative Journey of Philip E Hass

Introduction: Philip E Hass, a talented inventor based in Moss Beach, CA (US), has made significant contributions to the field of technology with his creative and groundbreaking inventions.

Latest Patents: Philip E Hass holds several patents in various technological domains, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: Throughout his illustrious career, Philip E Hass has been at the forefront of technological advancements, consistently pushing the boundaries of what is possible. His dedication to innovation and problem-solving has led to the development of cutting-edge solutions that have positively impacted numerous industries.

Collaborations: Philip E Hass has collaborated with leading tech companies, research institutions, and universities to further enhance his inventions and bring them to the market. His collaborative spirit and passion for innovation have been instrumental in his success as an inventor.

Conclusion: Philip E Hass's remarkable journey as an inventor is a testament to his unwavering commitment to pushing the boundaries of innovation. His groundbreaking inventions have not only transformed industries but have also inspired future generations of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.